Project 1
项目1
基本信息
- 批准号:10598771
- 负责人:
- 金额:$ 12.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS with Kaposi&aposs sarcomaAdherenceAdoptedAfricaAfrica South of the SaharaAgeAwarenessBiopsyCaringCervical Cancer ScreeningClinicClinicalCommunitiesCommunity NetworksCommunity WorkersConsentCountryCouplingCutaneousDataDetectionDiagnosisDiseaseEarly DiagnosisEarly treatmentEducationEffectivenessFosteringHIVHIV/AIDSHealthHealth PersonnelHealthcareHospitalsIncidenceInterventionKaposi SarcomaKnowledgeLesionLinkMalignant NeoplasmsMalignant neoplasm of cervix uteriMorbidity - disease rateNetwork-basedOceansOutcomePathologyPersonsPhysical ExaminationProviderRecurrenceReportingRespondentRoleSamplingServicesSiteSocial NetworkStandardizationStructureTanzaniaTeaching HospitalsTreatment outcomeUniversitiesZambiaantiretroviral therapycancer carecancer diagnosiscare providerscare systemseffectiveness evaluationempowermentexperienceimplementation strategyimprovedimproved outcomeintegrated caremortalityneoplasticpre-clinicalprogramsscale upscreeningskillstreatment center
项目摘要
Despite more than a decade of implementing universal access to antiretroviral therapy (ART) in sub-Saharan
Africa (SSA), Kaposi’s sarcoma (KS) remains the most common malignancy in people living with HIV/AIDS
(PLWH), causing significant morbidity and mortality. Compared to the US, ART implementation in SSA has not
resulted in a significant reduction of KS cases. For many PLWH in SSA, the only connection to health care is
through HIV care and treatment centers (CTC). Lack of recognition of early KS by both CTC care providers
and PLWH, and ineffective connection to diagnosis, care, and treatment when the disease presents in the
setting of HIV management at CTC may foster late presentation and ultimately, poor outcomes. Compared to
cervical cancer, where screening and early detection approaches have been successfully integrated into HIV
care for PLWH, efforts to detect, diagnose, and treat KS early are lacking. Since KS presents mostly
cutaneous, coupling KS detection to HIV management as has been done in cervical cancer for early detection
should readily improve early KS detection, definitive diagnosis, and linkage to care. As services for HIV
management are conducted through CTCs throughout SSA, these community-associated structures are the
best platform to integrate KS interventions and can be leveraged to increase early-stage presentation, early KS
diagnosis, and early treatment initiation. In this study, we will implement an integrated education package to
raise awareness and to impart the skills for early KS detection and diagnosis to PLWH, health care providers,
and community workers. This package includes recurrent educational sessions at CTCs in order to enhance
detection, diagnosis, and to initiate KS treatment early to improve outcomes of PLWH. It will also include a
social network-based strategy to enhance the sustainability of such an implementation program. We
hypothesize that an integrated care approach will increase the number and proportion of PLWH detected with
early KS, thereby improving early KS diagnosis and treatment to improve KS outcomes. There are 3 Specific
Aims. 1) Implement KS education, early detection, diagnosis, and linkage to care program at CTCs in Tanzania
and Zambia. 2) To enhance and sustain early KS detection, diagnosis, and linkage to care program through a
community network-based respondent-driven sampling (RDS) strategy in Tanzania and Zambia. 3) To
evaluate the effectiveness of integrating early KS detection, diagnosis, and RDS strategy in existing HIV care
services for PLWH in Tanzania and Zambia. Together, this will determine whether sensitization of providers
and PLWH to a combined HIV care and early KS detection approach is efficacious and viable in the setting.
This study is significant, as it will increase the proportion of PLWH examined for early KS detection, diagnosed,
and linked to cancer care. It will also focus on empowering and equipping providers and PLWH to make more
informed health decisions. This can be readily adopted and scaled up in Tanzania and Zambia, and
subsequently in other SSA to facilitate early KS diagnosis and treatment.
尽管撒哈拉以南地区普遍获得抗逆转录病毒治疗(ART)已经十多年了
非洲(SSA),卡波西肉瘤(KS)仍然是艾滋病毒/艾滋病患者最常见的恶性肿瘤
与美国相比,艾滋病毒感染者 (PLWH) 的发病率和死亡率并没有很高。
对于 SSA 的许多 PLWH 来说,与医疗保健的唯一联系是 KS 病例显着减少。
艾滋病毒护理和治疗中心 (CTC) 缺乏对早期 KS 的认可。
和 PLWH,以及当疾病出现在患者中时与诊断、护理和治疗的联系不力
与 CTC 相比,艾滋病毒管理的设置可能会导致晚期就诊,并最终导致不良结果。
宫颈癌,筛查和早期检测方法已成功融入艾滋病毒
由于 KS 大多出现,因此对 PLWH 的护理缺乏早期发现、诊断和治疗 KS 的努力。
皮肤,将 KS 检测与 HIV 管理结合起来,就像在宫颈癌中进行早期检测一样
应随时改善早期 KS 检测、明确诊断以及与艾滋病毒护理的联系。
管理是通过整个 SSA 的 CTC 进行的,这些与社区相关的结构是
整合 KS 干预措施的最佳平台,可用于增加早期表现、早期 KS
在本研究中,我们将实施综合教育方案,以促进诊断和早期治疗。
提高认识并向 PLWH、卫生保健提供者传授早期 KS 检测和诊断的技能,
该计划包括在 CTC 举办的定期教育课程,以增强能力。
检测、诊断并尽早开始 KS 治疗以改善 PLWH 的结果。
基于社交网络的战略,以增强此类实施计划的可持续性。
追求综合护理方法将增加发现的艾滋病病毒感染者的数量和比例
早期 KS,从而改善早期 KS 诊断和治疗,以改善 KS 结局。具体有 3 种。
目标。 1) 在坦桑尼亚 CTC 实施 KS 教育、早期检测、诊断和护理计划
2) 通过以下方式加强和维持早期 KS 检测、诊断以及与护理计划的联系。
坦桑尼亚和赞比亚基于社区网络的受访者驱动抽样 (RDS) 战略 3) 至。
评估将早期 KS 检测、诊断和 RDS 策略整合到现有 HIV 护理中的有效性
坦桑尼亚和赞比亚为艾滋病患者提供的服务将共同决定服务提供者是否提高认识。
艾滋病毒感染者和感染者接受艾滋病毒护理和早期 KS 检测相结合的方法在该环境中是有效且可行的。
这项研究意义重大,因为它将增加 PLWH 进行早期 KS 检测、诊断、
它还将重点关注为医疗服务提供者和艾滋病患者提供赋权和装备,以创造更多收入。
坦桑尼亚和赞比亚可以很容易地采用和推广知情的卫生决策,以及
随后在其他 SSA 中进行,以促进 KS 的早期诊断和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E HAGENSEE其他文献
MICHAEL E HAGENSEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E HAGENSEE', 18)}}的其他基金
Interaction of EBV and HPV in the development of cervical dysplasia in HIV+ women
EBV 和 HPV 在 HIV 女性宫颈发育不良中的相互作用
- 批准号:
7814393 - 财政年份:2009
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
8230703 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7495472 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7780076 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
8034749 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7616766 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
ORAL HPV INFECTION IN HIV CO-INFECTED INDIVIDUALS
HIV 合并感染者的口腔 HPV 感染
- 批准号:
7376285 - 财政年份:2005
- 资助金额:
$ 12.65万 - 项目类别:
ORAL HPV INFECTION IN HIV CO-INFECTED INDIVIDUALS
HIV 合并感染者的口腔 HPV 感染
- 批准号:
7204039 - 财政年份:2004
- 资助金额:
$ 12.65万 - 项目类别:
相似国自然基金
超级增强子驱动的TCFL4结合p300调控骨肉瘤脂代谢重编程的机制研究
- 批准号:82303201
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
染色质重塑基因SMARCAL1突变通过调节BRG1/ADAM17促软骨母细胞骨肉瘤干/祖细胞耐药的机制研究
- 批准号:82373391
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
BAP18调控FGL1转录介导肺肉瘤样癌免疫逃逸的机制研究
- 批准号:82373413
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于多功能仿生探针的骨肉瘤肺转移灶演进可视化及其干预策略研究
- 批准号:
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:
相似海外基金
Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia
为赞比亚艾滋病毒感染者提供综合癌症控制干预措施
- 批准号:
10878015 - 财政年份:2023
- 资助金额:
$ 12.65万 - 项目类别:
Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia
为赞比亚艾滋病毒感染者提供综合癌症控制干预措施
- 批准号:
10540828 - 财政年份:2022
- 资助金额:
$ 12.65万 - 项目类别:
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
- 批准号:
10646224 - 财政年份:2017
- 资助金额:
$ 12.65万 - 项目类别:
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
- 批准号:
10403014 - 财政年份:2017
- 资助金额:
$ 12.65万 - 项目类别: